Task order award- phase i clinical trials for the development of neurotherapeutics- DTI-117 in healthy volunteers/SAD and MAD CT
Active Awarded Last action
- Contract number
- 75N98026F00001
- Awardee
-
PPD Development LP UEI ZANENSW6C665
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,016,831
Award facts
- Contract value 40% obligated
-
- $2,016,831.00 Current, with exercised options
- $5,053,689.00 Potential, with all options
- Completion date 40% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Cape Fear, NC 28401, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,900,452 | |
| Original award | $116,379 |
About this award
The National Institute of Neurological Disorders and Stroke issued a $5.05 million delivery order to PPD Development LP on June 29, 2026, for Phase I clinical trials of DTI-117 in healthy volunteers (single ascending dose and multiple ascending dose cohorts) under the Phase I Clinical Trials for Development of Neurotherapeutics parent IDIQ.
Place of performance is Cape Fear, NC 28401. The order carries a cost-plus-fixed-fee pricing structure with an ultimate completion date of April 28, 2027. No set-aside was used.
Quick answers
Who was awarded contract 75N98026F00001?
75N98026F00001 was awarded to PPD Development LP by Office of Logisitics and Acquisition Operations (National Institutes of Health) on June 29, 2026.
How much is contract 75N98026F00001 worth?
The government has obligated $2,016,831 on 75N98026F00001. Its potential value, with all options, is $5,053,689.
Which agency awarded contract 75N98026F00001?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026F00001, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N98026F00001 an order under another contract?
Yes. 75N98026F00001 is a delivery order under HHSN271201600005I, an indefinite delivery contract, on Phase I Clinical Trials for Development of Neurotherapeutics.
Was contract 75N98026F00001 competed?
The extent of competition for 75N98026F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award